Table 1 Basic characteristics and hepatic histopathology of the patients
Characteristics | NAFLD |
|---|---|
Total | 91 |
Sex, Male/Female | 46/45 |
Age, y | 40 (32–56) |
Weight, kg | 81.55 ± 15.32 |
BMI, kg/m2 | 29.10 ± 4.06 |
Waist–hip ratio | 0.94 ± 0.06 |
T2DM, % | 65 (71.4%) |
Hypertension, % | 29 (31.9%) |
Platelet, /105 μL | 238.34 ± 70.05 |
Fasting glucose, mmol/L | 5.8 (5.1–7.0) |
2 h glucose, mmol/L | 12.47 ± 3.82 |
Haemoglobin A1c, % | 6.7 (5.8–8.1) |
Triglycerides, mmol/L | 1.84 (1.23–2.68) |
Total cholesterol, mmol/L | 4.39 (3.89–5.14) |
LDL cholesterol, mmol/L | 2.57 ± 0.85 |
HDL cholesterol, mmol/L | 0.99 (0.86–1.12) |
Albumin, g/L | 44 (42–47) |
Alanine aminotransferase, U/L | 61 (43–89) |
Aspartate aminotransferase, U/L | 37 (27–49) |
C-reactive protein, mg/L | 1.9 (1.1–3.7) |
LSM, kPa | 8.5 ± 3.5 |
Steatosis grade, n (%) | |
 1 5–33% | 18 (20.2) |
 2 33–66% | 52 (58.4) |
 3 > 66% | 19 (21.4) |
Lobular inflammation, n (%) | |
 0 None | 3 (3.4) |
 1 < 2 foci per 200× field | 35 (39.3) |
 2 2–4 foci per 200× field | 38 (42.7) |
 3 > 4 foci per 200× field | 13 (14.6) |
Liver cell ballooning, n (%) | |
 0 None | 2 (2.3) |
 1 Few balloon cells | 14 (15.7) |
 2 Many balloon cells | 73 (82.0) |
NAFL/NASH, n | 13/76 |
Fibrosis stage, n (%) | |
 0 None | 8 (8.8) |
 1 Perisinusoidal or periportal | 33 (36.2) |
 2 Perisinusoidal and portal/periportal | 30 (33.0) |
 3 Bridging fibrosis | 15 (16.5) |
 4 Cirrhosis | 5 (2 diagnosed with ultrasound) (5.5) |